Sangeetha Murugapandian

Epidemiology of Glomerular Disease in Southern Arizona

Sangeetha Murugapandian, Iyad Mansour, Mohammad Hudeeb et al. · Medicine · 2016 · 43 citations · Full text

Medicine, Nephrology, Pathology +14

Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations

Sangeetha Murugapandian, Babitha Bijin, Iyad Mansour et al. · Case Reports in Nephrology and Dialysis · 2015 · 19 citations · Full text

Medicine, Hematology, Oncology +17

Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) Infection

Mohanad Al‐Obaidi, Ahmet B. Gungor, Saman Nematollahi et al. · Open Forum Infectious Diseases · 2022 · 16 citations · Full text

Pharmacy, Immunology, Infectious Diseases +13

The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era

Mohanad Al‐Obaidi, Ahmet B. Gungor, Sangeetha Murugapandian et al. · The American Journal of Medicine · 2023 · 15 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era

Srilekha Sridhara, Ahmet B. Gungor, Halil Erol et al. · PLoS ONE · 2023 · 10 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16